Euphoria recently partnered with Plume, and the Solace app’s advice about hormone therapy is peppered with recommendations to subscribe to the expensive telehealth service.įrom the time postwar sexologists began treating transgender people in the United States in th mid-twentieth century, much access to trans medical care has been predicated on a patient’s ability to move through the world without excessive friction. While the first available apps in the Euphoria suite, the informational guide Solace and “self tracker” Clarity, are both free, the company also offers a Solace Plus concierge service, which will “help with one major transition objective” (like finding an informed consent clinic or a trans-friendly clothing retailer via an SMS hotline) for $25 per task. Folx’s quarterly hormone delivery service starts at $59 a month for estrogen and $89 a month for testosterone the price springs up from this baseline if the user selects a type of medication other than estrogen pills or injectable testosterone. Plume’s subscription goes for $99 a month, which does not cover the cost of hormones or supplies themselves, only telehealth appointments, labs, and issuing prescriptions to pharmacies. That facilitation, however, carries a steep price tag. With technological interventions and venture funding, these companies-whether they deliver tailored advice, virtual medical care, or hormones-on-demand-promise a transition that is smarter, faster, and more frictionless than ever, one that plugs as seamlessly as possible into the broader surrounding world. ![]() They announce an era of trans visibility, a break from the relative secrecy that shrouded much of the transition process in decades past. The promotional materials around these companies boast bold fonts, bright colors, and photographs of happy, relaxed people who have presumably used their technology to emerge cleanly from the other side of their chosen gender interventions. That’s larger than the entire film industry.” “Multiply that by an estimated population of 1.4 million transgender people, we’re taking about a market in excess of $200B. ![]() “Our estimates place the average cost of transition at $150,000 per person,” she said. Late last year, Euphoria’s CEO Robbi Katherine Anthony spoke with Forbes about the financial opportunities in the trans-tech field. Later that month, the transition tech company Euphoria, home to a suite of mobile apps that its CEO refers to as an “ Adobe equivalent” for transition, announced $250,000 in additional funding from the LGBTQ venture capital firm Gaingels and, improbably, Chelsea Clinton. Two telehealth and hormone prescription services, Plume and Folx, announced $14 million and $25 million in Series A venture capital funding, respectively, in early February. ![]() In the never-ending pursuit of wringing money out of even the most historically ignored populations, a recent series of venture capital investments has pointed to gender transition as a site of untapped potential profit.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |